Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
February 21, 1992
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site
S D Kimball, D M Floyd, J Das, et al.
Applied Optics
|
April 17, 2010
Large aperture harmonic conversion experiments at Lawrence Livermore National Laboratory
G J Linford, B C Johnson, J S Hildum, et al.
Bioorganic & Medicinal Chemistry
|
October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil
S D Kimball, J T Hunt, J C Barrish, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors
A A Seymour, J A Norman, M M Asaad, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects
K S Kim, J S Sack, J S Tokarski, et al.
Applied Optics
|
April 21, 2010
Large aperture harmonic conversion experiments at LLNL: comments
G J Linford, B C Johnson, J S Hildum, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase
C Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase
C Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity
J T Hunt, C Z Ding, R Batorsky, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)
N Murugesan, Z Gu, P D Stein, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
February 21, 1992
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site
S D Kimball, D M Floyd, J Das, et al.
Applied Optics
|
April 17, 2010
Large aperture harmonic conversion experiments at Lawrence Livermore National Laboratory
G J Linford, B C Johnson, J S Hildum, et al.
Bioorganic & Medicinal Chemistry
|
October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil
S D Kimball, J T Hunt, J C Barrish, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors
A A Seymour, J A Norman, M M Asaad, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects
K S Kim, J S Sack, J S Tokarski, et al.
Applied Optics
|
April 21, 2010
Large aperture harmonic conversion experiments at LLNL: comments
G J Linford, B C Johnson, J S Hildum, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase
C Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry
|
December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase
C Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity
J T Hunt, C Z Ding, R Batorsky, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)
N Murugesan, Z Gu, P D Stein, et al.
Page
of 5